In contrast, MSC-2 clusters derived from the bone marrow of patients with clear cell renal cell carcinoma metastases maintained the classic MSC markers NT5E and THY1 (CD90), but the expression of VCAM1, LEPR, and CXCL12 was reduced. The gene discussed is THY1; the disease is clear cell renal carcinoma.